Could a molecular switch repair central nervous system disorders?

via Mayo Clinic

Article Highlights

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS)
The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system.
"This sets the stage for development of new clinically relevant myelin regeneration strategies."
"It is important to say that we have not and are not advocating that patients take this inhibitor at this time," says Dr. Scarisbrick. "We have not used the drug in animals yet, and it is not ready to put in patients for the purpose of myelin repair. Using cell culture systems, we are showing that this has the potential to improve myelin regeneration.”
Additional research is needed to verify and advance the findings toward clinical practice.

SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)
Eighty-nine participants suffering from breakthrough or unvaccinated cases of COVID-19 were randomized evenly into high-dose, low-dose, and placebo groups. The phase 2 study showed that Pentarlandir ...
Global Drugs for Central Nervous System Diseases Market 2022 Competitive Strategy Analysis, Trend Analysis, and Forecast till 2028
Global Drugs for Central Nervous System Diseases Market 2022 by Company, Regions, Type and Application, Forecast ...
Drug for acute treatment of social anxiety disorder did not meet primary endpoint
A nasal spray to treat anxiety did not meet its primary endpoint and was not significantly better than the placebo.
From genetics to precision medicines for central nervous system disorders
Praxis Precision Medicines, Inc. uses a genetics-driven approach to develop potential best-in-class drugs for patients with central nervous system (CNS) disorders that are characterized by faulty ...
Fighting central nervous system disorders
Praxis Precision Medicines, Inc. uses a genetics-driven approach to develop potential best-in-class drugs for patients with central nervous system (CNS) disorders that are characterized by faulty ...

Bacteria use genetic switch to defend death by metals
Researchers have discovered a genetic switch in a common bacterium that helps defend itself against the human body’s natural immune system.
Now that the ‘serotonin myth’ is over, will a new age of depression treatment emerge?
The authors’ main finding is that depression is not the result of abnormalities in brain chemistry, particularly serotonin. And they cite evidence that the “serotonin myth” is not only believed by a ...
Researchers use MRI to show brain changes, differences in children with ADHD
Multitasking is not just an office skill. It's key to functioning as a human, and it involves something called cognitive flexibility—the ability to smoothly switch between mental processes. UNC ...
Chemistry breakthrough offers unprecedented control over atomic bonds
In what's being hailed as an important first for chemistry, an international team of scientists has developed a new technology that can selectively rearrange atomic bonds within a single molecule. The ...
Electric nanomotor made from DNA material
A research team has succeeded for the first time in producing a molecular electric motor using the DNA origami method. The tiny machine made of genetic material self-assembles and converts electrical ...